Test Price
2,400 AED✅ Home Collection Available
CLL Panel (Cytogenetics + FISH) in UAE | 2400 AED | 2026 DHA Guidelines
تحليل لوحة سرطان الدم الليمفاوي المزمن (الوراثة الخلوية وفحص التهجين الموضعي المتألق) في الإمارات | 2400 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Interpretation included.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الفحص المتقدم لتشخيص ومتابعة سرطان الدم الليمفاوي المزمن بدقة تبلغ 99.9% وفقًا لمعايير هيئة الصحة بدبي. خدمة سحب منزلي معتمدة وتفسير طبي عبر الهاتف.
Overview
The CLL Panel combines conventional cytogenetics (karyotyping) with targeted Fluorescence In‑Situ Hybridization (FISH) to detect the four most clinically significant genomic aberrations in chronic lymphocytic leukaemia: del(11q), trisomy 12, del(13q), and del(17p). This integrated assay provides a comprehensive risk‑stratification map, enabling haematologist‑oncologists to tailor therapy and monitor clonal evolution with confidence.
تجمع لوحة فحص سرطان الدم الليمفاوي المزمن بين التحليل الكروموسومي التقليدي وفحص التهجين الموضعي المتألق للكشف عن أشيع أربعة تغيرات وراثية ذات دلالة إنذارية، مما يسمح بتصنيف دقيق للمخاطر وتخطيط علاجي موجه.
| Feature | Our CLL Panel | Standard Karyotyping Only |
|---|---|---|
| Methodology | Cell Culture, G‑banded Karyotyping + FISH (del(11q), tri12, del(13q), del(17p)) | Conventional G‑banded Chromosome Analysis |
| Diagnostic Precision | 99.9% sensitivity for the tested loci; resolves cryptic deletions | ~85 % sensitivity; submicroscopic anomalies often missed |
| Turnaround Time | 10 working days | 10‑14 working days |
| Clinical Utility | Directly guides IGHV‑status‑independent risk stratification and targeted therapy choice | Primarily detects gross chromosomal gains/losses; limited prognostic resolution |
Physician Insight & Safety Protocol
Note from Dr. Prabhakar Reddy (DHA License: 61713011): As a specialist overseeing haematologic diagnostics, I want to emphasise that this CLL FISH panel delivers essential prognostic information; however, its interpretation must always be integrated with full blood counts, flow cytometry, and clinical evaluation. The presence of a high‑risk marker does not dictate an immediate treatment change in the absence of symptomatic progression. Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- A valid doctor’s prescription is mandatory except for pre‑surgical clearance, pregnancy, or travel requirements.
- Post‑bone‑marrow aspiration, seek immediate medical attention if you experience persistent heavy bleeding, fever >38°C, or signs of infection at the puncture site.
- Individuals with known unstable coagulopathy should be cleared by a haematologist before the procedure.
Patient FAQ & Clinical Guidance
1. What does the CLL FISH panel detect and why is it important?
The panel identifies four chromosomal anomalies—del(11q), trisomy 12, del(13q), and del(17p)—that determine CLL prognosis and influence the selection of molecular‑targeted agents like BTK inhibitors. تكشف اللوحة عن أربع طفرات صبغية تحدد مسار المرض وتساعد في اختيار العلاج الموجه بدقة.
2. How is the sample collected and what preparation is needed?
A small amount of bone marrow or peripheral blood is drawn by a certified phlebotomist during a home or clinic visit; no special fasting is required, but all blood‑thinning medications should be disclosed in advance. تُسحب العينة من نخاع العظم أو الدم المحيطي دون حاجة للصيام، مع الإفصاح عن مميعات الدم مسبقاً.
3. When will I receive my results and who explains them?
Results are ready within 10 days; a telephonic consultation with a clinical specialist is provided to explain the findings and their therapeutic implications. تصدر النتائج خلال ١٠ أيام مع استشارة هاتفية لشرح الدلالات العلاجية من قبل أخصائي.
UAE Regulatory Compliance
This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), the CDS Law 2026 for minors, and UAE PDPL data privacy standards. All genetic data is processed in an ISO 9001:2015‑certified facility (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453. Pre‑ counselling is mandatory for paediatric requests.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians